Cardiologs Holter Platform vs EchoNext
AI Verdict
Choose Cardiologs Holter Platform if…
Choose Cardiologs Holter Platform if your primary need is efficient and accurate analysis of long-term Holter ECG recordings for a wide range of arrhythmias. This AI-powered, cloud-based solution is ideal for cardiology practices and service providers looking to reduce analysis time by approximately 42% and streamline the detection of over 20 types of arrhythmias, offering vendor-neutral compatibility with various Holter devices.
View Cardiologs Holter Platform →Choose EchoNext if…
Choose EchoNext if your focus is on early detection of hidden structural heart disease, such as heart failure, valve disease, and pulmonary hypertension, using standard 12-lead ECGs. This FDA-cleared AI tool is particularly well-suited for broad screening in various clinical settings, from major hospitals to community practices, to identify patients who may require further evaluation with an echocardiogram.
View EchoNext →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiologs Holter Platform | EchoNext |
|---|---|---|
| Pricing | Contact sales | Starts at $600/month |
| Deployment | Cloud-based (SaaS) | Available through the OpenEvidence clinical decision support platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiologs Holter PlatformCardiologs Holter Platform is cloud-based, offering anytime, anywhere access and vendor-neutral compatibility with multiple Holter devices, which suggests greater flexibility and ease of integration into existing workflows. It also focuses on reducing analysis time by approximately 42% and generating easy-to-read reports, directly addressing user efficiency and clarity.
Clinical Value
EchoNextEchoNext has demonstrated superior accuracy in detecting structural heart disease from ECGs compared to cardiologists, even those assisted by AI. It has also been credited with leading to the first peer-reviewed case of a heart transplant attributable to AI-based disease detection, highlighting its significant impact on patient outcomes.
Pricing & Value
TieCardiologs Holter Platform uses a 'pay per ECG regardless the number of users' model, which could be cost-effective for practices with many users but fewer ECGs. EchoNext offers tiered pricing starting at $600/month, with discounts for annual plans and add-ons for premium features, providing flexibility for different organizational sizes. Without specific usage data or a detailed breakdown of Cardiologs' per-ECG cost, it's difficult to definitively declare one as offering better value across all scenarios.
Enterprise Readiness
Cardiologs Holter PlatformCardiologs Holter Platform is a cloud-based SaaS solution with secure data hosting on ISO/IEC 27001 certified AWS servers and EMR integration (Philips IntelliBridge Enterprise). Its vendor-neutral compatibility with multiple Holter devices further enhances its readiness for diverse enterprise environments.
Innovation
EchoNextEchoNext is highlighted as the world's first FDA-approved AI detection tool to analyze standard ECGs for hidden structural heart disease, including conditions like heart failure, valve disease, and pulmonary hypertension. This represents a novel application of AI in cardiology, moving beyond arrhythmia detection to identify more complex structural issues from a widely available and inexpensive test.
Support & Docs
TieBoth tools are FDA-cleared and HIPAA compliant, implying a certain level of documentation and regulatory adherence. However, specific details regarding customer support channels, training resources, or publicly available documentation are not provided for either tool in the given information or readily available through general web searches. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiologs Holter Platform | EchoNext |
|---|---|---|
| Name | Cardiologs Holter Platform | EchoNext |
| Company | Philips France Commercial | Pathway Labs |
| Description | The Cardiologs Holter Platform by Philips is an AI-powered, cloud-based solution for fast and accurate Holter ECG analysis, designed to detect over 20 types of arrhythmias and streamline cardiac diagnostics for healthcare professionals. | EchoNext is an FDA-cleared AI tool from Pathway Labs that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension. |
| Key Features | AI-powered deep learning technology for ECG analysis, Cloud-based platform, Vendor-neutral compatibility, Reduces Holter analysis time by approximately 42%, Detects over 20 types of arrhythmias, EMR integration (Philips IntelliBridge Enterprise), Secure data hosting on ISO/IEC 27001 certified AWS servers, Generates easy-to-read, automatically enriched reports. | AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support. |
| Specialties | Cardiology | Cardiology, Family Medicine, Hospital Medicine, Internal Medicine |
| Target Size | Not specified | Designed for broad access, from major hospitals to community practices. |
Videos
Demos, reviews, and walkthroughs featuring Cardiologs Holter Platform and EchoNext.